tiprankstipranks
Puma Biotechnology (PBYI)
NASDAQ:PBYI
Holding PBYI?
Track your performance easily

Puma Biotechnology (PBYI) Financial Statements

595 Followers

Puma Biotechnology Financial Overview

Puma Biotechnology's market cap is currently ―. The company's EPS TTM is $0.474; its P/E ratio is 5.77; Puma Biotechnology is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is $0.09. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 80.54M$ 47.08M$ 43.77M$ 72.18M$ 56.12M
Gross Profit$ 51.45M$ 36.42M$ 33.04M$ 47.85M$ 42.83M
EBIT$ 20.61M$ -4.15M$ -1.24M$ 16.16M$ 9.35M
EBITDA$ 23.49M$ -1.24M$ 1.66M$ 19.05M$ 12.22M
Net Income Common Stockholders$ 20.32M$ -4.53M$ -4.82M$ 12.27M$ 5.80M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 96.72M$ 96.83M$ 107.16M$ 95.94M$ 85.03M
Total Assets$ 220.72M$ 205.00M$ 214.15M$ 230.53M$ 203.60M
Total Debt$ 86.37M$ 98.59M$ 110.73M$ 111.49M$ 112.22M
Net Debt$ -10.36M$ 1.75M$ 3.57M$ 15.55M$ 27.19M
Total Liabilities$ 149.63M$ 156.49M$ 163.17M$ 177.09M$ 164.86M
Stockholders Equity$ 71.09M$ 48.51M$ 50.98M$ 53.44M$ 38.74M
Cash Flow-
Free Cash Flow$ 11.02M$ 1.01M$ 11.25M$ 10.41M$ 10.59M
Operating Cash Flow$ 11.04M$ 1.03M$ 11.25M$ 10.46M$ 10.62M
Investing Cash Flow$ 259.00K$ 703.00K$ -19.08M$ -8.17M$ 11.18M
Financing Cash Flow$ -11.18M$ -11.33M---
Currency in USD

Puma Biotechnology Earnings and Revenue History

Puma Biotechnology Debt to Assets

Puma Biotechnology Cash Flow

Puma Biotechnology Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis